BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 20679994)

  • 21. No effect of the IGF-1 gene rs35767 and rs17032362 polymorphisms in the etiology of idiopathic short stature.
    Tekcan D; Baş F; Atalar F; Aydin BK; Akan G; Tarhan T; Bundak R; Darendeliler F
    Exp Clin Endocrinol Diabetes; 2012 Jul; 120(7):395-400. PubMed ID: 22689104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IGF system in children with congenital disorders of glycosylation.
    Miller BS; Khosravi MJ; Patterson MC; Conover CA
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):892-7. PubMed ID: 19207313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
    Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
    Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased degradation of insulin-like growth factor-I in serum from feed-deprived steers.
    Wu M; Wang A; Bernard GC; Hall JB; Beal WE; Michael Akers R; Boisclair YR; Jiang H
    Domest Anim Endocrinol; 2008 Nov; 35(4):343-51. PubMed ID: 18760890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IGF-I, IGFBP-3 and ALS generation test in Turner syndrome.
    Pessoa de Queiroz AN; Collett-Solberg PF; Cardoso ME; Jusan RC; Vaisman M; Guimarães MM
    Growth Horm IGF Res; 2007 Jun; 17(3):254-60. PubMed ID: 17540594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of iodine deficiency on insulin-like growth factor-I, insulin-like growth factor-binding protein-3 levels and height attainment in malnourished children.
    Wan Nazaimoon WM; Osman A; Wu LL; Khalid BA
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):79-83. PubMed ID: 8796142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children.
    Mandel SH; Moreland E; Rosenfeld RG; Gargosky SE
    Endocrine; 1997 Dec; 7(3):351-60. PubMed ID: 9657073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Final height in patients with idiopathic short stature and high growth hormone responses to stimulation tests.
    Martinelli CE; Sader Milani S; Previato JK; Figueira M; Rangel Montenegro AP; Miraki-Moud F; Betancourth S; Moreira AC; Savage MO; Camacho-Hübner C
    Horm Res; 2007; 67(5):224-30. PubMed ID: 17135759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of the (CA)n repeat polymorphism of insulin-like growth factor-I and -202 A/C IGF-binding protein-3 promoter polymorphism with adult height in patients with severe growth hormone deficiency.
    Miletta MC; Scheidegger UA; Giordano M; Bozzola M; Pagani S; Bona G; Dattani M; Hindmarsh PC; Petkovic V; Oser-Meier M; Flück CE; Mullis PE
    Clin Endocrinol (Oxf); 2012 May; 76(5):683-90. PubMed ID: 22026507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterizing short stature by insulin-like growth factor axis status and genetic associations: results from the prospective, cross-sectional, epidemiogenetic EPIGROW study.
    Clayton P; Bonnemaire M; Dutailly P; Maisonobe P; Naudin L; Pham E; Zhang Z; Grupe A; Thiagalingam A; Denèfle P;
    J Clin Endocrinol Metab; 2013 Jun; 98(6):E1122-30. PubMed ID: 23596138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects, and diagnostic use in patients with growth hormone deficiency.
    Juul A; Møller S; Mosfeldt-Laursen E; Rasmussen MH; Scheike T; Pedersen SA; Kastrup KW; Yu H; Mistry J; Rasmussen S; Müller J; Henriksen J; Skakkebaek NE
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4408-15. PubMed ID: 9851786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homozygous and heterozygous expression of a novel mutation of the acid-labile subunit.
    van Duyvenvoorde HA; Kempers MJ; Twickler TB; van Doorn J; Gerver WJ; Noordam C; Losekoot M; Karperien M; Wit JM; Hermus AR
    Eur J Endocrinol; 2008 Aug; 159(2):113-20. PubMed ID: 18463107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene.
    Domené HM; Bengolea SV; Martínez AS; Ropelato MG; Pennisi P; Scaglia P; Heinrich JJ; Jasper HG
    N Engl J Med; 2004 Feb; 350(6):570-7. PubMed ID: 14762184
    [No Abstract]   [Full Text] [Related]  

  • 34. Noonan syndrome: relationships between genotype, growth, and growth factors.
    Limal JM; Parfait B; Cabrol S; Bonnet D; Leheup B; Lyonnet S; Vidaud M; Le Bouc Y
    J Clin Endocrinol Metab; 2006 Jan; 91(1):300-6. PubMed ID: 16263833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features of a new acid-labile subunit (IGFALS) heterozygous mutation: anthropometric and biochemical characterization and response to growth hormone administration.
    Grandone A; Miraglia del Giudice E; Cirillo G; Abbondanza C; Cioffi M; Romano T; Micillo F; Marzuillo P; Perrone L
    Horm Res Paediatr; 2014; 81(1):67-72. PubMed ID: 24356109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poor reproducibility of IGF-I and IGF binding protein-3 generation test in children with short stature and normal coding region of the GH receptor gene.
    Jorge AA; Souza SC; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2002 Feb; 87(2):469-72. PubMed ID: 11836270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation.
    Abuzzahab MJ; Schneider A; Goddard A; Grigorescu F; Lautier C; Keller E; Kiess W; Klammt J; Kratzsch J; Osgood D; Pfäffle R; Raile K; Seidel B; Smith RJ; Chernausek SD;
    N Engl J Med; 2003 Dec; 349(23):2211-22. PubMed ID: 14657428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver-specific overexpression of the insulin-like growth factor-I enhances somatic growth and partially prevents the effects of growth hormone deficiency.
    Liao L; Dearth RK; Zhou S; Britton OL; Lee AV; Xu J
    Endocrinology; 2006 Aug; 147(8):3877-88. PubMed ID: 16709615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D440N mutation in the acid-labile subunit of insulin-like growth factor complexes inhibits secretion and complex formation.
    Firth SM; Yan X; Baxter RC
    Mol Endocrinol; 2011 Feb; 25(2):307-14. PubMed ID: 21177759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case report: low circulating IGF-I levels due to Acid-Labile Subunit deficiency in adulthood are not associated with early development of atherosclerosis and impaired heart function.
    Rensing KL; van Duyvenvoorde HA; Cramer MJ; Teske AJ; Prokop M; Stroes ES; Wit JM; Hermus AR; Twickler TB
    Growth Horm IGF Res; 2011 Aug; 21(4):233-7. PubMed ID: 21664162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.